Search research articles
Contact Us
Filters
Showing results (301-310 of 7,541) with videos related to
Page
of 755
Sort By:
Postgraduate Medical Journal
|
August 1, 1978
Presentation of primary hyperparathyroidism to a general medical unit
P Sheridan
Nature Biotechnology
|
May 13, 2015
CRISPR germline editing reverberates through biotech industry
Cormac Sheridan
Nature Biotechnology
|
August 10, 2016
Biogen and UPenn join forces to commercialize gene therapies
Cormac Sheridan
Royal Society Open Science
|
April 10, 2020
Drones and global navigation satellite systems: current evidence from polar scientists
Iain Sheridan
Medical Economics
|
April 15, 1974
The alarming new assaults on doctor-patient privacy
Bart Sheridan
Nature Biotechnology
|
March 6, 2019
Drug developers switch gears to inhibit STING
Cormac Sheridan
Nature Biotechnology
|
November 10, 2018
Wnt is back in drugmakers' sights, but is it druggable?
Cormac Sheridan
Critical Care Medicine
|
January 26, 2007
Reducing blood loss in burn care
Rob Sheridan
Nature Biotechnology
|
May 9, 2006
TeGenero fiasco prompts regulatory rethink
Cormac Sheridan
Nature Biotechnology
|
July 11, 2007
Production technologies change flu vaccine landscape
Cormac Sheridan
Page
of 755
Search research articles
Search
Showing results (301-310 of 7,541) with videos related to
Sort By:
Page
of 755
Postgraduate Medical Journal
|
August 1, 1978
Presentation of primary hyperparathyroidism to a general medical unit
P Sheridan
Nature Biotechnology
|
May 13, 2015
CRISPR germline editing reverberates through biotech industry
Cormac Sheridan
Nature Biotechnology
|
August 10, 2016
Biogen and UPenn join forces to commercialize gene therapies
Cormac Sheridan
Royal Society Open Science
|
April 10, 2020
Drones and global navigation satellite systems: current evidence from polar scientists
Iain Sheridan
Medical Economics
|
April 15, 1974
The alarming new assaults on doctor-patient privacy
Bart Sheridan
Nature Biotechnology
|
March 6, 2019
Drug developers switch gears to inhibit STING
Cormac Sheridan
Nature Biotechnology
|
November 10, 2018
Wnt is back in drugmakers' sights, but is it druggable?
Cormac Sheridan
Critical Care Medicine
|
January 26, 2007
Reducing blood loss in burn care
Rob Sheridan
Nature Biotechnology
|
May 9, 2006
TeGenero fiasco prompts regulatory rethink
Cormac Sheridan
Nature Biotechnology
|
July 11, 2007
Production technologies change flu vaccine landscape
Cormac Sheridan
Page
of 755